Literature DB >> 931787

X-ray structure determination of (2S, 3R)-3-amino-2-hydroxy-4-phenylbutanoic acid, a new amino acid component of bestatin.

H Nakamura, H Suda, T Takita, T Aoyagi, H Umezawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 931787     DOI： 10.7164/antibiotics.29.102

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  4 in total

1.  Restoration of E-rosette formation by bestatin in patients with bladder cancer.

Authors:  H Yokoyama; T Umeda; K Kobayashi; H Akaza; T Niijima
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

2.  CD13 is a therapeutic target in human liver cancer stem cells.

Authors:  Naotsugu Haraguchi; Hideshi Ishii; Koshi Mimori; Fumiaki Tanaka; Masahisa Ohkuma; Ho Min Kim; Hirofumi Akita; Daisuke Takiuchi; Hisanori Hatano; Hiroaki Nagano; Graham F Barnard; Yuichiro Doki; Masaki Mori
Journal:  J Clin Invest       Date:  2010-08-09       Impact factor: 14.808

Review 3.  Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.

Authors:  Brigitte Bauvois; Daniel Dauzonne
Journal:  Med Res Rev       Date:  2006-01       Impact factor: 12.944

4.  Synthesis of (2S,3R)-3-amino-2-hydroxydecanoic acid and its enantiomer: a non-proteinogenic amino acid segment of the linear pentapeptide microginin.

Authors:  Rajendra S Rohokale; Dilip D Dhavale
Journal:  Beilstein J Org Chem       Date:  2014-03-17       Impact factor: 2.883
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.